Citigroup
EOLS icon

Citigroup’s Evolus EOLS Stock Holding History

Citigroup’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.3K Sell
6,406
-29,064
-82% -$141K ﹤0.01% 4751
2025
Q4 		$236K Buy
35,470
+13,591
+62% +$92.1K ﹤0.01% 3922
2025
Q3 		$134K Sell
21,879
-6,414
-23% -$50K ﹤0.01% 4155
2025
Q2 		$261K Sell
28,293
-23,063
-45% -$236K ﹤0.01% 3939
2025
Q1 		$618K Sell
51,356
-6,734
-12% -$88.1K ﹤0.01% 3560
2024
Q4 		$641K Buy
58,090
+12,502
+27% +$176K ﹤0.01% 3652
2024
Q3 		$739K Buy
45,588
+26,474
+139% +$370K ﹤0.01% 3486
2024
Q2 		$207K Buy
19,114
+6,236
+48% +$76.7K ﹤0.01% 3854
2024
Q1 		$180K Sell
12,878
-1,080
-8% -$14K ﹤0.01% 4064
2023
Q4 		$147K Buy
13,958
+7,988
+134% +$71.4K ﹤0.01% 4058
2023
Q3 		$54.6K Sell
5,970
-8,402
-58% -$75.3K ﹤0.01% 4104
2023
Q2 		$104K Buy
14,372
+12,811
+821% +$111K ﹤0.01% 4227
2023
Q1 		$13.2K Sell
1,561
-257
-14% -$2.32K ﹤0.01% 4645
2022
Q4 		$13.7K Sell
1,818
-8,550
-82% -$66.2K ﹤0.01% 4731
2022
Q3 		$83K Sell
10,368
-1,358
-12% -$14.4K ﹤0.01% 4176
2022
Q2 		$136K Buy
11,726
+9,367
+397% +$111K ﹤0.01% 4050
2022
Q1 		$26K Sell
2,359
-7,871
-77% -$67.1K ﹤0.01% 5020
2021
Q4 		$67K Buy
10,230
+5,140
+101% +$35.3K ﹤0.01% 4932
2021
Q3 		$39K Buy
5,090
+3,552
+231% +$36.7K ﹤0.01% 4875
2021
Q2 		$19K Buy
1,538
+94
+7% +$1.03K ﹤0.01% 5324
2021
Q1 		$19K Sell
1,444
-110,889
-99% -$1.02M ﹤0.01% 5279
2020
Q4 		$377K Buy
112,333
+19,847
+21% +$74.5K ﹤0.01% 4455
2020
Q3 		$362K Buy
92,486
+15,541
+20% +$56.8K ﹤0.01% 4136
2020
Q2 		$407K Buy
76,945
+13,007
+20% +$59.9K ﹤0.01% 4455
2020
Q1 		$265K Buy
63,938
+57,564
+903% +$488K ﹤0.01% 4486
2019
Q4 		$78K Buy
6,374
+5,971
+1,482% +$84.2K ﹤0.01% 5966
2019
Q3 		$6K Buy
403
+33
+9% +$541 ﹤0.01% 7268
2019
Q2 		$5K Sell
370
-19,175
-98% -$380K ﹤0.01% 7469
2019
Q1 		$441K Sell
19,545
-5,306
-21% -$115K ﹤0.01% 4320
2018
Q4 		$296K Buy
24,851
+24,294
+4,362% +$346K ﹤0.01% 4638
2018
Q3 		$10K Sell
557
-104
-16% -$2.25K ﹤0.01% 7345
2018
Q2 		$19K Sell
661
-208
-24% -$3.67K ﹤0.01% 6936
2018
Q1 		$8K Buy
+869
New +$9.94K ﹤0.01% 7108

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's EOLS Position: Q1 2026 in Review

Citigroup reduced its Evolus (EOLS) stake by 82% in Q1 2026, selling an estimated $141K and leaving 6,406 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4751.

Citigroup first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $739K in Q3 2024. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Citigroup held 6,406 shares of Evolus worth $26.3K as of Q1 2026.
  • Citigroup sold 29,064 Evolus shares in Q1 2026, an estimated $141K.
  • Evolus made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4751 holding.
  • Citigroup first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
  • Citigroup's Evolus position peaked at $739K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.